FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:5-9 July 7, 1994 Number 1 Next

	Full Text Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The effect of pregnancy on the risk of breast cancer is not clear. We tested the hypothesis that the risk of breast cancer increases transiently after pregnancy but then falls to a level below that of age-matched nulliparous women.

Methods We conducted a case-control study of a nationwide cohort in Sweden, using a computerized record linkage between the Cancer Registry and the Fertility Registry. The study subjects were women born from 1925 through 1960 who were resident citizens of Sweden at the time of the 1960 census. A total of 12,666 patients with breast cancer were compared with 62,121 age-matched control subjects. We used conditional logistic regression to estimate odds ratios for the development of breast cancer at different ages, according to maternal age at first delivery (in uniparous as compared with nulliparous women) and age at second delivery (in biparous as compared with uniparous women).

Results Uniparous women were at higher risk of breast cancer than nulliparous women for up to 15 years after childbirth and at lower risk thereafter. The excess risk was most pronounced among women who were older at the time of their first delivery (odds ratio 5 years after delivery among women 35 years old at first delivery, 1.26; 95 percent confidence interval, 1.10 to 1.44). Women who had two pregnancies had a less striking increase in risk.

Conclusions Pregnancy has a dual effect on the risk of breast cancer: it transiently increases the risk after childbirth but reduces the risk in later years. In women with two pregnancies, the short-term adverse effect is masked by the long-term protection imparted by the first pregnancy. A plausible biologic interpretation is that pregnancy increases the short-term risk of breast cancer by stimulating the growth of cells that have undergone the early stages of malignant transformation but that it confers long-term protection by inducing the differentiation of normal mammary stem cells that have the potential for neoplastic change.

Source Information

From the Department of Social Medicine (M.L.) and the Cancer Epidemiology Unit (M.L., A.E., H.-O.A.), University Hospital, Uppsala, Sweden; the Department of Epidemiology, Harvard School of Public Health, Boston (C.H., D.T., A.E., M.P., H.-O.A.); and the Cattedra di Igiene, Facolta di Medicina di Catanzaro, Universita di Reggio Calabria, Catanzaro, Italy (M.P.).

Address reprint requests to Dr. Lambe at the Department of Social Medicine, University Hospital, S-751 85 Uppsala, Sweden.

Full Text of this Article

Related Letters:

The Risk of Breast Cancer after Giving Birth
Thompson W. D., Lambe M., Hsieh C.-c.
Extract | Full Text  
N Engl J Med 1995; 332:63-64, Jan 5, 1995. Correspondence

Survivors of Breast Cancer
Potter J., Ship A. N., Love R. R., Burstein H. J., Winer E. P.
Extract | Full Text | PDF  
N Engl J Med 2001; 344:309-310, Jan 25, 2001. Correspondence

This article has been cited by other articles:

• Lord, S. J., Bernstein, L., Johnson, K. A., Malone, K. E., McDonald, J. A., Marchbanks, P. A., Simon, M. S., Strom, B. L., Press, M. F., Folger, S. G., Burkman, R. T., Deapen, D., Spirtas, R., Ursin, G. (2008). Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study. Cancer Epidemiol. Biomarkers Prev. 17: 1723-1730 [Abstract] [Full Text]  
• Britt, K., Ashworth, A., Smalley, M. (2007). Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14: 907-933 [Abstract] [Full Text]  
• Shakhar, K., Valdimarsdottir, H. B., Bovbjerg, D. H. (2007). Heightened Risk of Breast Cancer Following Pregnancy: Could Lasting Systemic Immune Alterations Contribute?. Cancer Epidemiol. Biomarkers Prev. 16: 1082-1086 [Abstract] [Full Text]  
• Largent, J. A., Capanu, M., Bernstein, L., Langholz, B., Mellemkjaer, L., Malone, K. E., Begg, C. B., Haile, R. W., Lynch, C. F., Anton-Culver, H., Wolitzer, A., Bernstein, J. L. (2007). Reproductive History and Risk of Second Primary Breast Cancer: The WECARE Study. Cancer Epidemiol. Biomarkers Prev. 16: 906-911 [Abstract] [Full Text]  
• Ferretti, G., Felici, A., Cognetti, F. (2007). Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword. Cancer Epidemiol. Biomarkers Prev. 16: 634-634 [Full Text]  
• Gupta, P. B., Proia, D., Cingoz, O., Weremowicz, J., Naber, S. P., Weinberg, R. A., Kuperwasser, C. (2007). Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor-Negative Cancers. Cancer Res. 67: 2062-2071 [Abstract] [Full Text]  
• Barlow, W. E., White, E., Ballard-Barbash, R., Vacek, P. M., Titus-Ernstoff, L., Carney, P. A., Tice, J. A., Buist, D. S. M., Geller, B. M., Rosenberg, R., Yankaskas, B. C., Kerlikowske, K. (2006). Prospective breast cancer risk prediction model for women undergoing screening mammography.. JNCI J Natl Cancer Inst 98: 1204-1214 [Abstract] [Full Text]  
• Andrieu, N., Goldgar, D. E., Easton, D. F., Rookus, M., Brohet, R., Antoniou, A. C., Peock, S., Evans, G., Eccles, D., Douglas, F., EMBRACE, , Nogues, C., Gauthier-Villars, M., Chompret, A., GENEPSO, , Van Leeuwen, F. E., Kluijt, I., GEO-HEBON, , Benitez, J., Arver, B., Olah, E., IBCCS Collaborators Group, , Chang-Claude, J. (2006). Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).. JNCI J Natl Cancer Inst 98: 535-544 [Abstract] [Full Text]  
• Gago-Dominguez, M., Castelao, J. E., Pike, M. C., Sevanian, A., Haile, R. W. (2005). Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 2829-2839 [Abstract] [Full Text]  
• Cnattingius, S., Torrang, A., Ekbom, A., Granath, F., Petersson, G., Lambe, M. (2005). Pregnancy Characteristics and Maternal Risk of Breast Cancer. JAMA 294: 2474-2480 [Abstract] [Full Text]  
• Hill, D. A., Gilbert, E., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., van't Veer, M., Storm, H., Pukkala, E., Stovall, M., Curtis, R. E., Allan, J. M., Boice, J. D., Travis, L. B. (2005). Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 106: 3358-3365 [Abstract] [Full Text]  
• Truong, T., Orsi, L., Dubourdieu, D., Rougier, Y., Hemon, D., Guenel, P. (2005). Role of Goiter and of Menstrual and Reproductive Factors in Thyroid Cancer: A Population-based Case-Control Study in New Caledonia (South Pacific), a Very High Incidence Area. Am J Epidemiol 161: 1056-1065 [Abstract] [Full Text]  
• Chavez-MacGregor, M., Elias, S. G., Onland-Moret, N. C., van der Schouw, Y. T., Van Gils, C. H., Monninkhof, E., Grobbee, D. E., Peeters, P. H.M. (2005). Postmenopausal Breast Cancer Risk and Cumulative Number of Menstrual Cycles. Cancer Epidemiol. Biomarkers Prev. 14: 799-804 [Abstract] [Full Text]  
• Hall, I. J., Moorman, P. G., Millikan, R. C., Newman, B. (2005). Comparative Analysis of Breast Cancer Risk Factors among African-American Women and White Women. Am J Epidemiol 161: 40-51 [Abstract] [Full Text]  
• Dano, H., Jacobsen, R., Hansen, K. D., Petersen, J. K., Lynge, E. (2004). Use of census data for construction of fertility history for Danish women. Scand J Public Health 32: 435-441 [Abstract]  
• Brinton, L. A., Scoccia, B., Moghissi, K. S., Westhoff, C. L., Althuis, M. D., Mabie, J. E., Lamb, E. J. (2004). Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 19: 2005-2013 [Abstract] [Full Text]  
• Phillips, K.-A., Milne, R. L., Friedlander, M. L., Jenkins, M. A., McCredie, M. R.E., Giles, G. G., Hopper, J. L. (2004). Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis. JCO 22: 699-705 [Abstract] [Full Text]  
• Foulkes, W D (2004). BRCA1 functions as a breast stem cell regulator. J. Med. Genet. 41: 1-5 [Abstract] [Full Text]  
• Siegelmann-Danieli, N., Tamir, A., Zohar, H., Papa, M. Z., Chetver, L. L., Gallimidi, Z., Stein, M. E., Kuten, A. (2003). Breast Cancer in Women With Recent Exposure to Fertility Medications is Associated With Poor Prognostic Features. Ann. Surg. Oncol. 10: 1031-1038 [Abstract] [Full Text]  
• Rookus, M. A. (2003). RESPONSE: Re: Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 Mutation Carriers. JNCI J Natl Cancer Inst 95: 1344-1344 [Full Text]  
• Palmer, J. R., Wise, L. A., Horton, N. J., Adams-Campbell, L. L., Rosenberg, L. (2003). Dual Effect of Parity on Breast Cancer Risk in African-American Women. JNCI J Natl Cancer Inst 95: 478-483 [Abstract] [Full Text]  
• Lillberg, K., Verkasalo, P. K., Kaprio, J., Teppo, L., Helenius, H., Koskenvuo, M. (2003). Stressful Life Events and Risk of Breast Cancer in 10,808 Women: A Cohort Study. Am J Epidemiol 157: 415-423 [Abstract] [Full Text]  
• Mann, R. J., Keri, R. A., Nilson, J. H. (2003). Consequences of Elevated Luteinizing Hormone on Diverse Physiological Systems: Use of the LH{beta}CTP Transgenic Mouse as a Model of Ovarian Hyperstimulation-induced Pathophysiology. Recent Prog Horm Res 58: 343-375 [Abstract] [Full Text]  
• Woo, J. C., Yu, T., Hurd, T. C. (2003). Breast Cancer in Pregnancy: A Literature Review. Arch Surg 138: 91-98 [Abstract] [Full Text]  
• Milliken, E. L., Ameduri, R. K., Landis, M. D., Behrooz, A., Abdul-Karim, F. W., Keri, R. A. (2002). Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice. Endocrinology 143: 3671-3680 [Abstract] [Full Text]  
• Peck, J. D., Hulka, B. S., Poole, C., Savitz, D. A., Baird, D., Richardson, B. E. (2002). Steroid Hormone Levels during Pregnancy and Incidence of Maternal Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 11: 361-368 [Abstract] [Full Text]  
• Stevens, A., Nelson, J. L. (2002). Maternal and Fetal Microchimerism: Implications for Human Diseases. NeoReviews 3: e11-19 [Full Text]  
• Wohlfahrt, J., Andersen, P. K., Mouridsen, H. T., Melbye, M. (2001). Risk of Late-stage Breast Cancer after a Childbirth. Am J Epidemiol 153: 1079-1084 [Abstract] [Full Text]  
• Potter, J., Ship, A. N., Love, R. R., Burstein, H. J., Winer, E. P. (2001). Survivors of Breast Cancer. NEJM 344: 309-310 [Full Text]  
• Melbye, M., Wohlfahrt, J., Lei, U., Pedersen, B. N., Mouridsen, H. T., Lambe, M., Michels, K. B. (2000). {alpha}-Fetoprotein Levels in Maternal Serum During Pregnancy and Maternal Breast Cancer Incidence. JNCI J Natl Cancer Inst 92: 1001-1005 [Abstract] [Full Text]  
• Gertig, D. M., Stillman, I. E., Byrne, C., Spiegelman, D., Schnitt, S. J., Connolly, J. L., Colditz, G. A., Hunter, D. J. (1999). Association of Age and Reproductive Factors with Benign Breast Tissue Composition. Cancer Epidemiol. Biomarkers Prev. 8: 873-879 [Abstract] [Full Text]  
• Egan, K. M., Quinn, J. L., Gragoudas, E. S. (1999). Childbearing History Associated With Improved Survival in Choroidal Melanoma. Arch Ophthalmol 117: 939-942 [Abstract] [Full Text]  
• Kroman, N., Wohlfahrt, J., Andersen, K. W., Mouridsen, H. T, Westergaard, T., Melbye, M. (1997). Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 315: 851-855 [Abstract] [Full Text]  
• Melbye, M., Wohlfahrt, J., Olsen, J. H., Frisch, M., Westergaard, T., Helweg-Larsen, K., Andersen, P. K. (1997). Induced Abortion and the Risk of Breast Cancer. NEJM 336: 81-85 [Abstract] [Full Text]  
• Rajan, J. V., Wang, M., Marquis, S. T., Chodosh, L. A. (1996). Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 93: 13078-13083 [Abstract] [Full Text]  
• Colditz, G. A. (1996). Postmenopausal Estrogens and Breast Cancer. Reproductive Sciences 3: 50-56  
• Thompson, W. D., Lambe, M., Hsieh, C.-c. (1995). The Risk of Breast Cancer after Giving Birth. NEJM 332: 63-64 [Full Text]  
• Stampfer, M, Grodstein, F, Spiers, D, Posthuma, W F M, Westendorp, R G J, Vandenbroucke, J P (1994). Cardioprotective effect of hormone replacement therapy Is not due to a selection bias. BMJ 309: 808b-809 [Full Text]